The importance of diversity in Pharmacovigilance

By Latin American Federation of the Pharmaceutical Industry (FIFARMA)

¿What is pharmacovigilance?

Have you ever wondered what the process is for monitoring the safety of medicines and their adverse effects? Is there any science behind it?  

Indeed, there is. It's called pharmacovigilance, the science responsible for detecting, preventing, and evaluating the risks associated with the use of medicines and vaccines. Its goal is to prevent or minimize harm to patients' health by monitoring and addressing any suspicion of adverse reactions. 

It's important to remember that before medicines are authorized for consumption, rigorous tests are conducted under controlled conditions known as clinical trials. However, these trials are carried out on a small group of people, excluding certain population groups. Therefore, it's difficult to anticipate all possible reactions that the medicine may cause in particular cases. 

For this reason, adverse drug reactions (ADRs) may manifest once the medicine has been marketed. To address these complications, it's necessary to refer to the country's pharmacovigilance systems and report potential incidents. Thus, adverse reactions are monitored to ensure the safety and efficacy of medicines in all populations, promote equity in healthcare, and facilitate the development of more personalized and effective treatments.

Diversity in Pharmacovigilance

Now that you know what pharmacovigilance is, it's crucial to recognize the importance of including data from a wide variety of populations during the monitoring of adverse effects in medicines. 

Diversity in pharmacovigilance involves the inclusion and analysis of data from a wide range of populations in monitoring the safety and efficacy of medicines, which entails considering variations in aspects such as ethnicity, gender, age, socio-economic and genetic conditions, and how these factors can influence the response to medicines. 

These are the key aspects to consider:

• Genetics and drug metabolism: Different ethnic groups may have genetic variations that affect the use of medicines. These genetic variations can cause the medicine to be eliminated from the body more slowly or more quickly than normal, which can lead to treatment failure, an increased risk of drug poisoning, or the occurrence of unwanted side effects.

• Differences in disease prevalence: Certain diseases may be more prevalent in some populations than in others, which can affect how medicines are used and how they respond to them.

• Socio-economic and cultural factors: These factors can influence access to healthcare, adherence to treatment, and attitudes towards medication and health in general.

• Age and gender: Age and gender can affect pharmacokinetics (how the body absorbs, distributes, metabolizes, and eliminates a medicine) and pharmacodynamics (how the medicine affects the body).

Why is it important?

Medicines do not affect all people in the same way, and understanding these differences is crucial for effective and safe treatment. Diversity in pharmacovigilance allows for a complete understanding of the risks and benefits of medicines in all populations, leading to safer and more effective use of medicines and improved health outcomes for everyone.

Some of the benefits include:

1. Improving drug safety and efficacy: By understanding how different groups respond to a medicine, its safety and efficacy profile can be improved.
2. Developing personalized treatment guidelines: The information obtained can help personalize treatment recommendations for different groups.
3. Reducing health disparities: Ensures that the benefits and risks of medicines are understood in a broader context, addressing the health needs of all populations.
4. Promoting equity in healthcare: All patients, regardless of their background, deserve access to medicines that have been tested and are safe for people like them. This is especially important in underrepresented or marginalized communities.

Challenges

After recognizing the importance of diversity in pharmacovigilance, it's important to mention the main challenges during practice. 

• Participant recruitment: Sometimes it's difficult to recruit a diverse group of volunteer participants for clinical trials.
• Datos limitados: Puede haber una falta de datos disponibles sobre cómo los medicamentos afectan a diferentes grupos.
• Cultural and Ethical Sensitivity: It's important to approach these studies with sensitivity to diverse cultures and ethical practices.

What's next for the future?

By addressing these challenges, we can pave the way for a more inclusive and effective practice of pharmacovigilance, ensuring that all patients receive safe and adequate care. To achieve this, it's necessary to combine efforts in executing inclusive recruitment strategies with diverse participants. Additionally, it's essential to promote education about the importance of diversity in pharmacovigilance, not only in the healthcare sector but also in the classrooms of the general public. 

On the other hand, the future for addressing genetic variability is promising. Currently, pharmacogenetics and pharmacogenomics are emerging fields focusing on the analysis of unique genetic characteristics and their interaction with medicines. 

These disciplines aim to create more effective and safer treatments, personalizing doses according to each individual's genetic makeup, with the goal of maximizing treatment efficacy and minimizing risks. In short, personalized medicine is becoming increasingly closer.

Pharmacovigilance, when practiced with a focus on diversity, has the potential to transform lives and healthcare systems worldwide. Let's continue to create solutions to significantly improve health outcomes and move towards more equitable and effective healthcare.